ArticleThe American journal of case reports2025
Severe Neonatal Asphyxia Associated with Ureaplasma urealyticum Infection: A Case Report.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Ureaplasma urealyticum (UU) is a common microorganism that has been associated with a variety of obstetric and neonatal complications, such as infertility, stillbirth, histologic chorioamnionitis, neonatal sepsis, respiratory infections, and central nervous system infections. However, it is rare for it to cause severe neonatal asphyxia. This rarity is the focus of our case report, which aims to highlight the potential severity of UU infections in newborns. CASE REPORT A male neonate was delivered vaginally at 40+5 weeks of gestation, with a history of premature rupture of membranes at 7 hours and low amniotic fluid volume. After birth, he had no spontaneous breathing at birth, with cyanosis around the mouth and extremities and flaccid limbs. The Apgar score was a low 3, indicating severe asphyxia. Immediate medical interventions were undertaken, including cardiopulmonary resuscitation, tracheal intubation, and airway clearing. Despite these efforts, the newborn required transfer to our hospital with the assistance of an invasive ventilator. Upon admission, UU DNA was detected in the sputum at 3.25×10⁴ copies/mL. He received erythromycin for infection, mechanical ventilation, milrinone combined with sildenafil to reduce pulmonary arterial hypertension, and glycerol fructose to reduce intracranial pressure. Although these treatments successfully controlled the infection, the infant suffered significant neurological damage. Tragically, the family decided to cease treatment, and the neonate died at 12 days of age. CONCLUSIONS Ureaplasma urealyticum infection can cause severe neonatal asphyxia. We report the present case to raise awareness about the importance of early detection and intervention for UU in pregnant women to improve maternal and neonatal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.